Management of spasticity in multiple sclerosis by intrathecal baclofen

Acta Neurochirurgica, Supplementum

Volumn , Issue 97 PART 1, 2007, Pages 189-192

  Dario, Alessandro ^a   Tomei, G ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

Intrathecal baclofen; multiple sclerosis; spasticity

Indexed keywords

BACLOFEN; CENTRAL MUSCLE RELAXANT;

HUMAN; INTRASPINAL DRUG ADMINISTRATION; MULTIPLE SCLEROSIS; REVIEW; SPASTICITY;

BACLOFEN; HUMANS; INJECTIONS, SPINAL; MULTIPLE SCLEROSIS; MUSCLE RELAXANTS, CENTRAL; MUSCLE SPASTICITY;

EID: 85052610367     PISSN: 00651419     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-211-33079-1_26     Document Type: Short Survey

References (25)

1. Akman MN, Loubser PG, Donovan WH (1993) Intrathecal baclofen: does tolerance occur? Paraplegia 31:516-520
2. Boviatsis EJ, Kouyialis AT, Korfias S, Sakas DE (2005) Functional outcome of intrathecal baclofen administration for severe spasticity. Clin Neurol Neurosurg 107:289-295
3. Bramanti P, D'Aleo G, Rifici C, Alagna A, Cannata A, Sessa E, Di Bella P, Marra G (2004) Quality of life of patients with telemetric pumps for intrathecal baclofen infusion: data and limitations of assessment scales. Funct Neurol 19:227-231
4. Dario A, Scamoni C, Picano M, Fortini G, Cuffari S, Tomei G (2005) The infection risk of intrathecal drug infusion pumps after multiple refill procedures. Neuromodulation 8:36-39
5. Dario A, Tomei G (2004) A benefit-risk assessment of baclofen in severe spinal spasticity. Drug Saf 27:799-818
6. Denys P, Mane M, Azouvi P (1998) Side effects of chronic intrathecal baclofen on erection and ejaculation in patients with spinal cord lesions. Arch Phys Med Rehabil 79:494-496
7. Dressnandt J, Conrad B (1996) Lasting reduction of severe spasticity after ending chronic treatment with intrathecal baclofen. J Neurol Neurosurg Psychiatry 60:168-173
8. Francisco GE (2004) The role of intrathecal baclofen therapy in the upper motor neuron syndrome. Eura Medicophys 40:131-143
9. Gercek A, Baykan N, Dagcinar A, Ozek MM (2004) Does general anesthesia potentiate the GABA-ergic action of intrathecal baclofen? J Neurosurg Anesthesiol 16:323-324
10. Hemingway C, McGrogan J, Freeman JM (2001) Energy requirements of spasticity. Dev Med Child Neurol 43:277-278
11. Lehmann A, Mattsson JP, Edlund A, Johansson T, Ekstrand AJ (2003) Effects of repeated administration of baclofen to rats on GABAB receptor binding sites and subunit expression in the brain. Neurochem Res 28:387-393
12. Levin ED, Weber E, Icenogle L (2004) Baclofen interactions with nicotine in rats: effects on memory. Pharmacol Biochem Behav 79:343-348
13. Mertens P, Parise M, Garcia-Larrea L (1995) Long-term clinical, electrophysiological and urodynamic effects of chronic intrathecal baclofen infusion for treatment of spinal spasticity. Acta Neurochir Suppl 64:17-25
14. Middel B, Kuipers-Upmeijer H, Bouma J, Staal M, Oenema D, Postma T, Terpstra S, Stewart R (1997) Effect of intrathecal baclofen delivered by an implanted programmable pump on health related quality of life in patients with severe spasticity. J Neurol Neurosurg Psychiatry 63:204-299
15. Nielsen JF, Sinkjaer T (2004) Guided intrathecal baclofen administration by using soleus stretch reflex in moderate-severe spastic multiple sclerosis patients with implanted pump. Mult Scler 10:521-525
16. Ordia JI, Fischer E, Adamski E, Chagnon KG, Spatz EL (2002) Continuous intrathecal baclofen infusion by a programmable pump in 131 consecutive patients with severe spasticity of spinal origin. Neuromodulation 5:16-24 (Pubitemid 34127088)
17. Pandyan AD, Johnson GR, Price CI, Curless RH, Barnes MP, Rodgers H (1999) A review of the properties and limitations of the Ashworth and modified Ashworth scales as measures of spasticity. Clin Rehabil 13:373-383
18. Penn RD (1992) Intrathecal baclofen for spasticity of spinal origin: seven years of experience. J Neurosurg 77:236-240
19. Penn RD, Kroin JS (1985) Continuous intrathecal baclofen for severe spasticity. Lancet 2:125-127
20. Plassat R, Perrouin Verbe B, Menei P, Menegalli D, Mathe JF, Richard I (2004) Treatment of spasticity with intrathecal baclofen administration: long-term follow-up, review of 40 patients. Spinal Cord 42:686-693
21. Rizzo MA, Hadjimichael OC, Preiningerova J, Vollmer TL (2004) Prevalence and treatment of spasticity reported by multiple sclerosis patients. Mult Scler 10:589-595
22. Schuele SU, Kellinghaus C, Shook SJ, Boulis N, Bethoux FA, Loddenkemper T (2005) Incidence of seizures in patients with multiple sclerosis treated with intrathecal baclofen. Neurology 64:1086-1087
23. Taha J, Favre J, Janszen M, Galarza M, Taha A (2004) Correlation between withdrawal symptoms and medication pump residual volume in patients with implantable SynchroMed pumps. Neurosurgery 55:390-394
24. Tardieu G, Shentoub S, Delarue R (1954) Research on a technic for measurement of spasticity. Rev Neurol (Paris) 91:143-144
25. Zahavi A, Geertzen JH, Middel B, Staal M, Rietman JS (2004) Long term effect (more than five years) of intrathecal baclofen on impairment, disability, and quality of life in patients with severe spasticity of spinal origin. J Neurol Neurosurg Psychiatry 75:1553-1557